We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+10.33%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$70.7B
AUM Growth
+$2.25B
Cap. Flow
-$3.76B
Cap. Flow %
-5.32%
Top 10 Hldgs %
10.84%
Holding
2,524
New
171
Increased
580
Reduced
1,478
Closed
87

Top Sells

Rank Stock Value
1
ALL icon
Allstate
ALL
+$693M
2
INTC icon
Intel
INTC
+$664M
3
T icon
AT&T
T
+$547M
4
PARA
Paramount Global Class B
PARA
+$295M
5
DIS icon
Walt Disney
DIS
+$173M

Sector Composition

Rank Sector Weight
1 Technology 17.73%
2 Healthcare 15.12%
3 Financials 14.74%
4 Industrials 12.02%
5 Consumer Discretionary 9.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WASH icon
2376
Washington Trust Bancorp
WASH
$732M
$7K ﹤0.01%
144
-69
-32% -$3.35K
QTTB icon
2377
Q32 Bio
QTTB
$450M
$7K ﹤0.01%
40
-12
-23% -$2.53K
ORAN
2378
DELISTED
Orange
ORAN
$7K ﹤0.01%
588
+55
+10% +$664
ABTX
2379
DELISTED
Allegiance Bancshares
ABTX
$7K ﹤0.01%
182
-86
-32% -$3.28K
CTMX icon
2380
CytomX Therapeutics
CTMX
$705M
$6K ﹤0.01%
789
-374
-32% -$2.96K
EFC
2381
Ellington Financial
EFC
$1.68B
$6K ﹤0.01%
360
-170
-32% -$2.68K
KNSA icon
2382
Kiniksa Pharmaceuticals
KNSA
$4.83B
$6K ﹤0.01%
333
-158
-32% -$3.23K
MBI icon
2383
MBIA
MBI
$288M
$6K ﹤0.01%
659
-313
-32% -$2.42K
NFBK
2384
DELISTED
Northfield Bancorp
NFBK
$6K ﹤0.01%
398
-188
-32% -$2.64K
NGNE icon
2385
Neurogene
NGNE
$696M
$6K ﹤0.01%
26
-12
-32% -$3.07K
QCRH icon
2386
QCR Holdings
QCRH
$1.65B
$6K ﹤0.01%
128
-61
-32% -$2.61K
SAP icon
2387
SAP
SAP
$187B
$6K ﹤0.01%
45
+12
+36% +$1.52K
FBMS
2388
DELISTED
The First Bancshares, Inc.
FBMS
$6K ﹤0.01%
168
-79
-32% -$2.65K
CMO
2389
DELISTED
Capstead Mortgage Corp.
CMO
$6K ﹤0.01%
908
-430
-32% -$2.53K
GSBC icon
2390
Great Southern Bancorp
GSBC
$863M
$5K ﹤0.01%
97
-46
-32% -$2.46K
KREF
2391
KKR Real Estate Finance Trust
KREF
$472M
$5K ﹤0.01%
290
-138
-32% -$2.53K
PASG icon
2392
Passage Bio
PASG
$15.9M
$5K ﹤0.01%
13
-7
-35% -$2.99K
CFB
2393
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$5K ﹤0.01%
377
-178
-32% -$2.29K
NWLI
2394
DELISTED
National Western Life Group, Inc. Class A
NWLI
$5K ﹤0.01%
21
-10
-32% -$2.15K
MTEM
2395
DELISTED
Molecular Templates, Inc.
MTEM
$5K ﹤0.01%
26
-13
-33% -$2.28K
ASMB icon
2396
Assembly Biosciences
ASMB
$506M
$4K ﹤0.01%
76
-23
-23% -$1.52K
RLMD icon
2397
Relmada Therapeutics
RLMD
$544M
$4K ﹤0.01%
116
-55
-32% -$1.92K
SNN icon
2398
Smith & Nephew
SNN
$12.9B
$4K ﹤0.01%
+105
New +$4.34K
AE
2399
DELISTED
Adams Resources & Energy Inc
AE
$4K ﹤0.01%
130
QTNT
2400
DELISTED
Quotient Limited Ordinary Shares
QTNT
$4K ﹤0.01%
29
-14
-33% -$2.77K

Similar funds

Macquarie Group's Q1 2021 Portfolio in Review

As of Q1 2021, Macquarie Group held 2,524 positions worth $70.7B, up 3.3% from $68.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group withdrew a net $3.76B in Q1 2021, closing 87 positions and reducing 1,478 holdings. Its most notable exit was iShares Core S&P Total US Stock Market ETF, an estimated $140M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Macquarie Group opened a new position in Sunrun worth $77.7M.

  • Macquarie Group's largest Q1 2021 buy was Sunrun: 1,285,424 shares worth $77.7M.
  • Macquarie Group added most to MetLife in Q1 2021, an estimated $627M increase.
  • Macquarie Group's biggest Q1 2021 reduction was Allstate, cutting an estimated $693M.
  • Macquarie Group fully exited iShares Core S&P Total US Stock Market ETF in Q1 2021, selling an estimated $140M.
  • Macquarie Group's ten largest holdings make up 11% of its $70.7B portfolio in Q1 2021.
  • Macquarie Group opened 171 new positions and closed 87 in Q1 2021.
  • Macquarie Group's portfolio value rose 3.3% quarter-over-quarter to $70.7B.

Based on Macquarie Group's 13F filing for Q1 2021, filed 14 May 2021.